Kymera Therapeutics, Inc. vs 4D Molecular Therapeutics, Inc., risk disclosures compared

1topics both disclose

4only Kymera Therapeutics, Inc.

3only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Kymera Therapeutics, Inc.	4D Molecular Therapeutics, Inc.
Internal Control	6	6

Only Kymera Therapeutics, Inc.

Topic	Filings
Business Continuity	23
Material Weakness	6
AI Governance	3
Regulatory Reporting	2

Only 4D Molecular Therapeutics, Inc.

Topic	Filings
Restatement	5
Ransomware	3
Third Party Risk Management	3

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Kymera Therapeutics, Inc. · 4D Molecular Therapeutics, Inc. · All companies